Home
Dexcom DXCM paid Continental Strategy $75K for lobbying in Q2 2026 · Health Issues, Medical
Trade details
- Type
- Lobbying report
- Amount
- $75,000
- Quarter
- Q2 2026
- Stock
- Dexcom DXCM
- Client
- Dexcom
- Reported
- 26/07/19
Up 0.0% from last quarter
What else happened in Dexcom around then
Filed or reported within 30 days of the trade day · 05/31~07/30Dexcom's other lobbying reports
- Dexcom
LobbyingDexcom
LobbyingDexcom
DXCM
$40K
$40K
Reported 07/20
for Q2
- Dexcom
LobbyingDexcom
LobbyingDexcom
DXCM
$370K
$370K
Reported 07/20
for Q2
- Dexcom
LobbyingDexcom
LobbyingDexcom
DXCM
$40K
$40K
Reported 07/20
for Q2
- Dexcom
LobbyingDexcom
LobbyingDexcom
DXCM
$50K
$50K
Reported 07/20
for Q2
- Dexcom
LobbyingDexcom
LobbyingDexcom
DXCM
$380K
$380K
Reported 04/20
for Q1